Literature DB >> 19566823

Post-inflammatory modification of colonic afferent mechanosensitivity.

P A Hughes1, S M Brierley, L A Blackshaw.   

Abstract

1. The present review discusses interactions between the immune and nervous systems in post-infectious irritable bowel syndrome (PI-IBS). 2. Visceral pain is the single symptom that most affects the quality of life of patients with irritable bowel syndrome (IBS), yet it is the least successfully managed. An underlying hypersensitivity of colonic afferents to mechanical stimuli has long been implicated in visceral pain in IBS, but little more is known of the physiological aetiology. 3. The PI-IBS patients are a cohort of IBS patients who attribute their symptoms to a preceding gastrointestinal infection by pathogens such as Campylobacter or Salmonella. Current evidence suggests that the immune system remains activated in these patients and contributes to their visceral hypersensitivity. This is characterized by a shift in the phenotype of circulating immune cells towards a Type 1 (Th1 predominating) state. Products from these immune cells sensitize colonic afferents to mechanical stimuli. 4. Rectal instillation of trinitrobenzene sulphonic acid induces a Th1-mediated inflammatory response, consistent with clinical observations in PI-IBS. The visceral hypersensitivity observed in this model is biphasic, with an initial onset characterized by visceral hypersensitivity correlating with histological damage followed by a delayed phase that occurs after histological recovery. Interestingly, this chronic visceral hypersensitivity is mediated by afferents in closest apposition to blood vessels, but furthest from the initial site of damage. 5. Both clinical and experimental evidence indicates that chronic dysregulation of the immune system induces visceral afferent hypersensitivity and, therefore, may be the central mechanism underlying PI-IBS.

Entities:  

Mesh:

Year:  2009        PMID: 19566823     DOI: 10.1111/j.1440-1681.2009.05248.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  17 in total

1.  Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat.

Authors:  Anthony C Johnson; Beverley Greenwood-Van Meerveld; John McRorie
Journal:  Dig Dis Sci       Date:  2011-05-12       Impact factor: 3.199

2.  Prolonged sympathetic innervation of sensory neurons in rat thoracolumbar dorsal root ganglia during chronic colitis.

Authors:  C-M Xia; D G Colomb; H I Akbarali; L-Y Qiao
Journal:  Neurogastroenterol Motil       Date:  2011-05-24       Impact factor: 3.598

Review 3.  [Neurobiology of visceral pain].

Authors:  W Jänig
Journal:  Schmerz       Date:  2014-06       Impact factor: 1.107

4.  Loss of visceral pain following colorectal distension in an endothelin-3 deficient mouse model of Hirschsprung's disease.

Authors:  Vladimir P Zagorodnyuk; Melinda Kyloh; Sarah Nicholas; Heshan Peiris; Simon J Brookes; Bao Nan Chen; Nick J Spencer
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

5.  Key factors in developing the trinitrobenzene sulfonic acid-induced post-inflammatory irritable bowel syndrome model in rats.

Authors:  Hong-Yan Qin; Hai-Tao Xiao; Justin C Y Wu; Brian M Berman; Joseph J Y Sung; Zhao-Xiang Bian
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

Review 6.  Genetics of human gastrointestinal sensation.

Authors:  M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2013-04-17       Impact factor: 3.598

7.  Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Authors:  Joel Castro; Luke Grundy; Annemie Deiteren; Andrea M Harrington; Tracey O'Donnell; Jessica Maddern; Jessi Moore; Sonia Garcia-Caraballo; Grigori Y Rychkov; Rilei Yu; Quentin Kaas; David J Craik; David J Adams; Stuart M Brierley
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

8.  Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndrome.

Authors:  Birgit Adam; Chris Tsopelas; Tobias Liebregts; F Dylan Bartholomeusz; Gerald Holtmann
Journal:  J Gastroenterol       Date:  2013-01-12       Impact factor: 7.527

Review 9.  Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.

Authors:  Peter Holzer; Florian Reichmann; Aitak Farzi
Journal:  Neuropeptides       Date:  2012-09-11       Impact factor: 3.286

10.  Identification of the visceral pain pathway activated by noxious colorectal distension in mice.

Authors:  Melinda Kyloh; Sarah Nicholas; Vladimir P Zagorodnyuk; Simon J Brookes; Nick J Spencer
Journal:  Front Neurosci       Date:  2011-02-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.